NCT02203357 A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults Status COMPLETED Phase PHASE4
NCT02186977 Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID Status COMPLETED Phase PHASE1
NCT02153320 Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02152709 Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine Status COMPLETED Phase PHASE3
NCT02148562 Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity Status UNKNOWN Phase N/A
NCT02135666 Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084) Status WITHDRAWN Phase PHASE4
NCT02108444 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients Status COMPLETED Phase N/A
NCT02096263 Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants Status COMPLETED Phase PHASE3
NCT02094833 DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants Status COMPLETED Phase PHASE3
NCT02057263 The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT02055365 Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers Status COMPLETED Phase NA
NCT02052661 This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa Status COMPLETED Phase PHASE4
NCT02040636 Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis Status COMPLETED Phase PHASE2
NCT02032160 A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines Status COMPLETED Phase NA
NCT02025842 Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma Status COMPLETED Phase N/A